Post Submission Regulatory Services
Navigating Post Submission Challenges with Seamless Transition from Submission to Approval
Navigating Post Submission Challenges with Seamless Transition from Submission to Approval
We offers comprehensive post-submission regulatory services to help pharmaceutical manufacturers fulfil their regulatory responsibilities, monitor product performance, and address any new compliance concerns, ensuring continuous adherence and preservation of market authorization for medical devices, pharmaceuticals, biologics, and IVD products.
Post submission services involve activities after a product receives initial approval, ensuring on-going compliance with regulatory requirements, product safety, and managing any changes or updates throughout the product’s lifecycle, which are crucial for maintaining product safety.
Our team of experienced regulatory specialists offers post submission services to manufacturers, utilizing our extensive knowledge of various regulatory frameworks and regions to ensure compliance and successful implementation of regulatory tactics.
Access to a team of regulatory professionals with global expertise in post-submission processes and tailored solutions to address specific regulatory challenges.
Proactively monitor and implement updates to stay ahead of regulatory changes, while reducing non-compliance and potential regulatory actions through continuous monitoring and risk management.
Utilize advanced tools and technologies to streamline post-submission regulatory activities, ensuring efficiency and accuracy.
Expertise and infrastructure can optimize resource allocation and reduce overhead costs, while focusing on core business activities and managing post-submission regulatory requirements.
Through rigorous post-market surveillance and quality management practices, promptly addressing potential risks to protect patient safety and maintain market confidence
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S Certification) is
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.